1. Home
  2. BBNX vs HBCP Comparison

BBNX vs HBCP Comparison

Compare BBNX & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • HBCP
  • Stock Information
  • Founded
  • BBNX 2015
  • HBCP 1908
  • Country
  • BBNX United States
  • HBCP United States
  • Employees
  • BBNX N/A
  • HBCP N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • HBCP Banks
  • Sector
  • BBNX Health Care
  • HBCP Finance
  • Exchange
  • BBNX Nasdaq
  • HBCP Nasdaq
  • Market Cap
  • BBNX 463.4M
  • HBCP 381.6M
  • IPO Year
  • BBNX 2025
  • HBCP 2008
  • Fundamental
  • Price
  • BBNX $11.14
  • HBCP $43.56
  • Analyst Decision
  • BBNX Strong Buy
  • HBCP Buy
  • Analyst Count
  • BBNX 6
  • HBCP 2
  • Target Price
  • BBNX $26.67
  • HBCP $55.00
  • AVG Volume (30 Days)
  • BBNX 690.5K
  • HBCP 32.5K
  • Earning Date
  • BBNX 05-06-2025
  • HBCP 04-21-2025
  • Dividend Yield
  • BBNX N/A
  • HBCP 2.37%
  • EPS Growth
  • BBNX N/A
  • HBCP N/A
  • EPS
  • BBNX N/A
  • HBCP 4.55
  • Revenue
  • BBNX $65,123,999.00
  • HBCP $132,366,000.00
  • Revenue This Year
  • BBNX $29.49
  • HBCP N/A
  • Revenue Next Year
  • BBNX $34.93
  • HBCP $5.15
  • P/E Ratio
  • BBNX N/A
  • HBCP $9.53
  • Revenue Growth
  • BBNX 442.93
  • HBCP N/A
  • 52 Week Low
  • BBNX $8.89
  • HBCP $33.30
  • 52 Week High
  • BBNX $24.50
  • HBCP $52.77
  • Technical
  • Relative Strength Index (RSI)
  • BBNX N/A
  • HBCP 47.35
  • Support Level
  • BBNX N/A
  • HBCP $40.74
  • Resistance Level
  • BBNX N/A
  • HBCP $43.52
  • Average True Range (ATR)
  • BBNX 0.00
  • HBCP 1.67
  • MACD
  • BBNX 0.00
  • HBCP 0.11
  • Stochastic Oscillator
  • BBNX 0.00
  • HBCP 63.83

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans. Its primary expenses are interest expense on deposits and borrowings and general operating expenses.

Share on Social Networks: